Business
Exagen Announces Acceptance of Multiple Abstracts at ACR 2023 Annual Meeting
SAN DIEGO, California, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today the
About this update from Exagen Inc.
[{"type":"text","content":"SAN DIEGO, California, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today the acceptance of five abstracts at the 2023 American College of Rheumatology’s (ACR) annual meeting, ACR Convergence 2023, being held November 10-15, 2023, at the San Diego Convention Center in San Diego, California. Below is the list of accepted abstracts, with links to each: Sunday, November 12, 2023 Poster Presentation | Presented by Doruk Erkan | Abstract #0099Title: Cell-bound Complement Activation Products in Antiphospholipid Antibody-positive Patients Without Other Systemic Autoimmune DiseasesSession Title: Poster Session ASession Time: 9:00 – 11:00am PT Poster Presentation | Presented by Jennifer Rogers | Abstract #0557Title: Longitudinal Evaluation of Cell-bound Complement Activation Products in Patients with SLESession Title: Poster Session ASession Time: 9:00 – 11:00am PT Poster Presentation | Presented by Andrew Concoff| Abstract #0575Title: The Real-World Utility of a Lupus Activity Monitoring Panel in the United States Community Rheumatologist PracticeSession Title: Poster Session ASession Time: 9:00 – 11:00am PT Poster Presentation | Presented by Andrew Concoff| Abstract #0576Title: Enhancing Systemic Lupus Erythematosus Diagnosis: Comparative Performance Characteristics of TC4d and Anti-T-Cell Antibodies with Conventional BiomarkersSession Title: Poster Session ASession Time: 9:00 – 11:00am PT Tuesday, November 14, 2023 Poster Presentation | Presented by Vasileios Kyttaris| Abstract #2273Title: Predicting SLE Disease Activity with Blood Biomarkers: A Step Towards Precision MedicineSession Title: Poster Session CSession Time: 9:00 – 11:00am PT About Exagen Inc. Exagen is a leading provider of autoimmune testing and its purpose as an organization is to provide clarity in autoimmune disease decision making with the goal of improving patients’ clinical outcomes. Exagen is located in San Diego County, California. For more information, please visit Exagen.com and follow @ExagenInc on X. Forward Looking Statements Exagen cautions you that statements contained in this press release regarding matters that are not historical facts are forward-looking statements. These statements are based on Exagen’s current beliefs and expectations. Such forward-looking statements includ...